GET THE APP

Method Development and Validation For the Simultaneous Estimation of Irbesartan and Hydrochlorothiazide in Tablet Formulation by HPTLC | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.

Abstract

Method Development and Validation For the Simultaneous Estimation of Irbesartan and Hydrochlorothiazide in Tablet Formulation by HPTLC

Author(s): A. R. Magesh and M. D. Dhanaraju

High performance thin layer chromatographic (HPTLC) method has been developed and validated for simultaneous investigation of Irbesartan and Hydrochlorothiazide in tablet formulation. Chromatographic separation was performed on aluminium plates precoated with silica gel 60F254, with methanol: ethyl acetate (7: 3 % v/v) as mobile phase. Detection was performed densitometrically at 254 nm. The Rf values of Irbesartan and Hydrochlorothiazide were 0.24 ± 0.10and 0.42 ± 0.06, respectively. Linearity was found to be in the concentration range of 150-900 ng/spot for Irbesartan and 25- 150 ng/spot for Hydrochlorothiazide, accuracy (100.05 % for Irbesartan and 100.26 % for Hydrochlorothiazide) and specificity, in accordance with ICH guidelines. The method can be used for routine analysis of Irbesartan and Hydrochlorothiazide in tablet formulation.


PDF

Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank
Google Scholar citation report
Citations : 25868

Der Pharma Chemica received 25868 citations as per Google Scholar report

Der Pharma Chemica peer review process verified at publons
Der Pharma Chemica- Journals on pharmaceutical chemistry